Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Juvenile Diabetes Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013196
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to manage diabetes. It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma. JDRF provides diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. The organization has operations in Australia, Canada, Denmark, Israel, Netherlands and the UK. It partners with pharmaceuticals, healthcare and automobile companies to eradicate type one diabetes. JDRF is headquartered in New York, the US.

Juvenile Diabetes Research Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2011 to YTD 2017 10
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
T1D Innovations Raises US$5 Million In Venture Financing 13
Partnerships 14
Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 14
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 15
JDRF Enters into Agreement with Pacific Diabetes Technologies 16
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 17
MannKind Partners with JDRF 18
Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 19
Regimmune Enters into Research Agreement with JDRF and Pfizer 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 23
Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 24
KalVista Pharma Enters Into Research Agreement With JDRF 25
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 26
iCo Therapeutics Enters Into Co-Development Agreement With JDRF For iCo-007 27
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 28
Juvenile Diabetes Enters Into Co-Development Agreement With Amylin Pharma 29
Equity Offering 30
Bigfoot Biomedical Raises Funds in Equity Financing 30
AnTolRx to Raise USD4 Million in Private Placement of Shares 31
Sernova to Raise USD2.5 Million in Private Placement of Shares 32
Juvenile Diabetes Research Foundation – Key Competitors 33
Juvenile Diabetes Research Foundation – Key Employees 34
Juvenile Diabetes Research Foundation – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Corporate Communications 38
Apr 20, 2016: JDRF Announces New International Board of Directors Chairman Mark Fischer-Colbrie 38
Jan 16, 2016: WellCare Gives $5,000 to Juvenile Diabetes Research Foundation to Support Efforts to Find a Cure and New Treatments 39
Government and Public Interest 40
Aug 31, 2017: Role of gut bacteria in averting Type 1 diabetes 40
Aug 01, 2017: Case Western Reserve University: Missing Signals Leads to Diabetic Nerve Injury 42
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 43
Feb 07, 2017: JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin 44
Jan 12, 2017: JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes 45
Oct 12, 2016: JDRF Funds U of T Engineering Research to Improve Cell Transplantation to Treat Type 1 Diabetes 46
Sep 13, 2016: Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California 47
Jul 12, 2016: Defymed Receives Support from JDRF to Fight Type 1 Diabetes 48
Jul 07, 2016: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 49
Jul 07, 2016: Midatech Pharma: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 50
Product News 51
Jul 14, 2016: JDRF and TrialReach Launch a New, No Cost Clinical Trial Matching Tool to Solve Critical Challenges in Diabetes Research 51
Other Significant Developments 52
Feb 25, 2016: JDRF and Sanofi Announce Expansion of their Joint Research Collaboration to Include Development of Glucose Responsive Insulin Therapies for Treatment of Insulin-Dependent Diabetes 52
Feb 10, 2016: JDRF Announces the Formation of a New Research Advisory Committee to Support Fight Against Type 1 Diabetes 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Juvenile Diabetes Research Foundation, Deals By Therapy Area, 2011 to YTD 2017 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2011 to YTD 2017 10
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
T1D Innovations Raises US$5 Million In Venture Financing 13
Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 14
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 15
JDRF Enters into Agreement with Pacific Diabetes Technologies 16
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 17
MannKind Partners with JDRF 18
Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 19
Regimmune Enters into Research Agreement with JDRF and Pfizer 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 23
Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 24
KalVista Pharma Enters Into Research Agreement With JDRF 25
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 26
iCo Therapeutics Enters Into Co-Development Agreement With JDRF For iCo-007 27
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 28
Juvenile Diabetes Enters Into Co-Development Agreement With Amylin Pharma 29
Bigfoot Biomedical Raises Funds in Equity Financing 30
AnTolRx to Raise USD4 Million in Private Placement of Shares 31
Sernova to Raise USD2.5 Million in Private Placement of Shares 32
Juvenile Diabetes Research Foundation, Key Competitors 33
Juvenile Diabetes Research Foundation, Key Employees 34
Juvenile Diabetes Research Foundation, Key Employees (cont..) 36

★海外企業調査レポート[Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Golden Concord Holdings Ltd:電力:M&Aディール及び事業提携情報
    Summary Golden Concord Holdings Ltd (GCHL) is a diversified company. The company operates through its business divisions such as power, photovoltaic, oil and gas, smart commute and finance. Its photovoltaic division carries out manufacturing of photovoltaic materials, development of photovoltaic pow …
  • Nationwide Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Nationwide Children's Hospital (Nationwide Children's) is a provider of pediatric health care and research services. The hospital offers pediatric services in the areas of gastroenterology, hematology and nutrition, heart care, left lip and palate, oncology ad bone marrow transplantation. It …
  • Applied Industrial Technologies Inc (AIT):企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Petro Vista Energy Corp (PTV.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and production of oil and gas properties. It offers upstream oil and gas services with exploration and produ …
  • J.L. Clark Inc:企業の戦略的SWOT分析
    J.L. Clark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Konsortium Transnasional Berhad:企業の戦略・SWOT・財務情報
    Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SPAR Osterreichische Warenhandels AG:企業の戦略的SWOT分析
    SPAR Osterreichische Warenhandels AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • HSBC Holdings Plc:企業の戦略・SWOT・財務情報
    HSBC Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary HSBC Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Proxy Biomedical Ltd-医療機器分野:企業M&A・提携分析
    Summary Proxy Biomedical Ltd (PBL) is a medical device company that research, develops and manufactures biomaterials for medical implant products. The company’s products include composite mesh, flat sheet 2D and 3D mesh, hernia plugs, resorbable synthetic mesh, resorbable surgical mesh, specialty su …
  • Hovid Berhad (HOVID):企業の財務・戦略的SWOT分析
    Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Duke Energy Carolinas LLC:企業の発電所・SWOT分析2018
    Duke Energy Carolinas LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • WEG SA:戦略・SWOT・企業財務分析
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Mahle GmbH:企業の戦略・SWOT・財務分析
    Mahle GmbH - Strategy, SWOT and Corporate Finance Report Summary Mahle GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Greenhill & Co Inc:企業の戦略・SWOT・財務情報
    Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report Summary Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • LeMaitre Vascular Inc (LMAT)-医療機器分野:企業M&A・提携分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Odakyu Electric Railway Co., Ltd.:企業の戦略・SWOT・財務情報
    Odakyu Electric Railway Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Odakyu Electric Railway Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Concho Resources Inc (CXO):石油・ガス:M&Aディール及び事業提携情報
    Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in the US. Co …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Ophthotech Corp (OPHT):企業の財務・戦略的SWOT分析
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It also provides Fovista, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆